Skip to Content

Amphora Approval Status

FDA Approved: No
Brand name: Amphora
Generic name: L-lactic acid, citric acid, and potassium bitartrate
Dosage form: Vaginal Gel
Company: Evofem, Inc.
Treatment for: Birth Control

Amphora (L-lactic acid, citric acid, and potassium bitartrate) is a non-hormonal vaginal gel in development for use as a contraceptive, and for the prevention of urogenital chlamydia in women.

Development Status and FDA Approval Process for Amphora

DateArticle
Feb 21, 2018Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia
Sep 22, 2015Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora as a Contraceptive
Jul  6, 2015Evofem, Inc. Submits NDA to U.S. FDA for Amphora as a Contraceptive

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide